1. Home
  2. CALC vs BMR Comparison

CALC vs BMR Comparison

Compare CALC & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • BMR
  • Stock Information
  • Founded
  • CALC 2011
  • BMR 2009
  • Country
  • CALC United States
  • BMR Israel
  • Employees
  • CALC 15
  • BMR N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • BMR Computer Software: Prepackaged Software
  • Sector
  • CALC Health Care
  • BMR Technology
  • Exchange
  • CALC Nasdaq
  • BMR Nasdaq
  • Market Cap
  • CALC 45.4M
  • BMR 47.4M
  • IPO Year
  • CALC N/A
  • BMR 2023
  • Fundamental
  • Price
  • CALC $3.23
  • BMR $2.68
  • Analyst Decision
  • CALC Strong Buy
  • BMR
  • Analyst Count
  • CALC 2
  • BMR 0
  • Target Price
  • CALC $14.50
  • BMR N/A
  • AVG Volume (30 Days)
  • CALC 52.6K
  • BMR 230.0K
  • Earning Date
  • CALC 11-12-2025
  • BMR 08-13-2025
  • Dividend Yield
  • CALC N/A
  • BMR N/A
  • EPS Growth
  • CALC N/A
  • BMR N/A
  • EPS
  • CALC N/A
  • BMR N/A
  • Revenue
  • CALC N/A
  • BMR $3,131,000.00
  • Revenue This Year
  • CALC N/A
  • BMR $21.21
  • Revenue Next Year
  • CALC N/A
  • BMR N/A
  • P/E Ratio
  • CALC N/A
  • BMR N/A
  • Revenue Growth
  • CALC N/A
  • BMR 5.96
  • 52 Week Low
  • CALC $1.42
  • BMR $1.86
  • 52 Week High
  • CALC $5.65
  • BMR $6.59
  • Technical
  • Relative Strength Index (RSI)
  • CALC 52.57
  • BMR 37.99
  • Support Level
  • CALC $3.13
  • BMR $2.76
  • Resistance Level
  • CALC $3.33
  • BMR $3.11
  • Average True Range (ATR)
  • CALC 0.20
  • BMR 0.17
  • MACD
  • CALC -0.00
  • BMR -0.03
  • Stochastic Oscillator
  • CALC 38.24
  • BMR 6.67

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

Share on Social Networks: